Tirzepatide is an FDA-approved dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management
Over-the-counter arnica gel or topical vitamin K products show modest benefit in some patients, though evidence is mixed
Injection Method Subcutaneous injection with an insulin syringe same technique as other peptides
Microdosing is more improvisational and less accurate, which is why doctors generally advise against it
Additionally, several patients taking tirzepatide have reported DVT and pulmonary embolisms in the FDA Adverse Event Reporting System (FAERS) after taking the medication
This is how we can limit the number of patients per provider, and how we ensure that you get thorough and thoughtful care under our values of being heard, feeling accepted, and receiving compassionate care